OMER Omeros Corporation Kompaniyaning sof daromadi

OMER (omeros.com) - kompaniyaning tovar belgisi

Omeros Corporation (OMER) narxlarining harakati 0.13 joriy darajasini aks ettirmoqda. Biznes immun patologiyalariga qarshi dori vositalarini ishlab chiqishga tayanadi, garchi tartibga soluvchi qarorlarga bog'liqlik ma'lum xavflarni yuzaga keltirsa-da. Kompaniyaning barqarorligi kamyob kasalliklar uchun maqsadli terapiyalarni aniqlash va og'ir yallig'lanishni kamaytirish maqsadida tibbiyot markazlari va olimlar bilan strategik hamkorlik orqali mustahkamlanmoqda.

omeros.com (OMER): Sof foyda 04.07.2022dan 01.11.2026gacha

omeros.com (OMER) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Omeros|OMER - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Omeros Corporation|OMER - Kompaniyaning to‘liq qiymati
- balans bo'yicha xususiy kapital ma'lumotlari:
Bitta aksiya uchun buxgalteriya qiymati Omeros|OMER - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti omeros.com|OMER - Kompaniyaning jami aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Barcha qarzlarning o‘z mablag‘lariga nisbati Omeros Corporation|OMER - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Omeros|OMER - Kompaniya qarzlari|Sof aktivlarga qarzlar Omeros Corporation|OMER - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Omeros|Tezkor likvidlik ko‘rsatkichi omeros.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
OMER - Kompaniyaning sof foydasi
Kompaniyaning asosiy tahlili:OMER - Omeros Corp.
Omeros Corporation tomonidan chiqariladigan mahsulotlar

Omeros Corporation (OMER) uchun foyda biofarmatsevtika dori vositalarini ishlab chiqishning yakuniy samaradorligini aks ettiradi. Ushbu ko'rsatkich barcha operatsion xarajatlar va qarz xizmati xarajatlari chegirib tashlanganidan keyin qolgan sof mablag'larni o'lchaydi. Kompaniyaning marginal daromadlari tahlili kredit stavkalarining emitentning moliyaviy barqarorligiga ta'sirini baholash imkonini beradi. Ushbu ko'rsatkichning tebranishlari asosiy mahsulotlarni tasdiqlash bilan bog'liq tartibga soluvchi xatarlarga bog'liqdir. Foydaning barqarorligi investorlarning ehtiyotkorligiga qaramay, brendning bozordagi yashab qolish qobiliyatini tasdiqlaydi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniyaning sof daromadi regencellbioscience.com RGC|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|Sof daromad ACADIA Pharma ACAD|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Viking Therapeutics Corp (VKTX) - Kompaniyaning sof daromadi|SUPN - Kompaniyaning sof foydasi|Yakuniy foyda CPRX (catalystpharma.com)|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Harmony Biosciences Inc (HRMY)|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Amylyx Corp (AMLX) - Sof moliyaviy natija|Sof daromad TRVI (Trevi Therapeutics)|PRAX (praxismedicines.com) - Yakuniy foyda|Sof foyda AVXL (Anavex Life Sciences Corp.)|CBLL - Sof daromad|PRTA - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Alector, Inc.|Annexon, Inc. (ANNX) - Kompaniyaning sof foydasi|neurogene.com - Yakuniy foyda|Kompaniyaning sof foydasi AC Immune SA|Voyager Therapeutics Inc - Soliqdan keyingi foyda|Kompaniyaning sof foydasi Neumora Therapeutics Inc (NMRA)|SCLX - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Tevogen Bio Holdings TVGN|Yakuniy foyda ACOG|Cognition Therapeutics - Sof foyda|IKT - Sof foyda|SAVA (Cassava) - Sof daromad|ASRT: Soliqlar to‘langandan keyingi foyda|COYA (Coya Therapeutics Inc) - Sof foyda|VistaGen Therapeutics Inc (VTGN) - Sof moliyaviy natija|Kompaniyaning sof foydasi Ovid Therapeutics Inc. (OVID)|ABOS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi CervoMed Inc CRVO|ATHE: Kompaniya foydasi|CLNN - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi PepGen Inc.|Jupiter Neurosciences Inc (JUNS) - Kompaniyaning sof foydasi|Sof daromad Relmada Therapeutics Inc|ANVS (Annovis Bio Corp) - Sof foyda|Kompaniyaning sof daromadi Grace Tx GRCE|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|KLTO (anewmeds.com) - Yakuniy foyda|Kompaniyaning sof foydasi NeuroSense Therapeutics Ltd. NRSN|RVPH: Kompaniya foydasi|MetaVia, Inc. - Sof foyda|Kompaniyaning sof daromadi NeurAxis Inc|HSDT (heliusmedical.com) - Sof daromad|Passage Bio (PASG) - Sof foyda|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|NERV: Yakuniy foyda|Kompaniyaning sof foydasi Athira (ATHA)|ADXN - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Alzamend Neuro ALZN|Cyclerion Therapeutics Inc. (CYCN) - Kompaniyaning sof daromadi|PTIX - Kompaniyaning sof foydasi|Pasithea Therapeutics (KTTA) - Sof daromad|CRGT: Sof foyda|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|Kompaniyaning sof foydasi Brainstorm Cell|CARA: Yakuniy foyda|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|ELYM - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Sof moliyaviy natija Longboard (LBPH)|MRNS: Sof daromad|Yakuniy foyda NKGN (nkgenbiotech.com)|NRBO: Sof foyda|Sof daromad Sage Therapeutics Inc.|Kompaniyaning sof foydasi Neurotrope|Kompaniyaning sof daromadi Trevena Inc TRVN|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|WENA (Anew Medical Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi Cerevel Therapeutics, Inc. CERE